prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: PATH HAS SPECIMEN nnDATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MAST. CLINICAL HISTORY: PATH_HAS SPECIMEN. MATERIAL SUBMITTED:/ RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATTVE CONSULTATION: CONSULT: Right breast: 8.0 by 7.0 by 2.5 cm, with 1.7 by 1.5 by 1.5 cm tumor. All margins grossly negative. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. DMMUNOPEROXIDASE IDENTIFICATION or ESTROGEN AND PROGESTERONI RECEPTORS IS CARRIED OUT ON SLIDE. "Al". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (95%) AND PROCESTERONE RECEPTOR. (95%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVI. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUNOSTAININC IS CARRIED OUT ON MAGEE SURGICAL. BLOCK "D2" (BREAST CANCER). USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE DNTRACELLULAR DOMAIN or c-. erb82) WITEOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS- IDENTIFIED. THEREFORE, c-erb82. (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 01. FINAL DIAGNOSIS: FINAL DIAGNOSIS: RIGHT SEGMENTAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMO), INTERNEDIATE HISTOLOGIC AND NUCLEAR GRADE. - NOTTINGHAM SCORE 5. - SIZE OF TUMOR 1.7 CM. - RETROGRADE EXTENSION INTO LOBULES IS SEEN. - LYMPHOCYTIC INFILTRATION SEE. - MICROCALCIFICATIONS. - PROLIFERATIVE FIBROCYSTIC CHANGES AND INTRADUCTAL PAPILLOMA. - SCLEROSING ADENOSIS. - MARGINS ARE FREE.

expanded version (tokens=940) : 
 The main points of the breast pathology report are:

- Histological classification: Infiltrating ductal carcinoma, intermediate histologic and nuclear grade, with a size of 1.7 cm.
- Subtype: Luminal A.
- Necrosis: No information on necrosis is mentioned in the report.
- Tumor infiltrating lymphocytes: The report states that lymphocytic infiltration is seen.
- Histological grade: Intermediate histologic and nuclear grade with Nottingham score 5.
- Nuclear grade: Intermediate.
- Lymphovascular invasion: No information on lymphovascular invasion is provided in the report.
- Calcification: Microcalcifications are seen.
- Receptor status: Both estrogen receptor (ER) and progesterone receptor (PR) are positive, with 95% distinct intranuclear staining identified for each. HER-2/neu immunostaining is carried out, which is interpreted as negative (score 0).
- Ancillary testing results: No additional ancillary testing results are mentioned in the report.

Overall, the report identifies a luminal A subtype of infiltrating ductal carcinoma with positive ER and PR receptor status and negative HER-2/neu status. It also notes the presence of lymphocytic infiltration, microcalcifications, and other benign changes in the breast tissue. Margins are reported as free.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1052) : 
 The pathology report reveals a 1.7cm intermediate-grade, infiltrating ductal carcinoma with luminal A subtype and positive ER/PR expression (95%) and negative HER-2/neu status. Lymphocytic infiltration is present, along with microcalcifications and other benign changes, but margins are free.

